KDM4A promoted docetaxel resistance in castration-resistant prostate cancer (C-R PC) cell lines by regulating cytoskeleton remodeling through miR-34a/Stathmin 1/β3-Tubulin axis [185]. Here, KDM4A is linked to prostate carcinoma.